2022: Tromboz, Gemostaz i Reologiya, Nr. 1
Тромбоз, гемостаз и реология

Tromboz, Gemostaz I Reologiya
scientific and practical journal

ISSN 2078–1008 (Print); ISSN 2687-1483 (online)
Tromboz, Gemostaz i Reologiya, Nr. 1

Original papers

Lyudmila Lyapina, Sergey Sorokoletov, Tamara Obergan, Margarita Lyapina, Marina Kalugina
21-27
Compound of aspartic acid with heparin as a tool for thrombogenesis prevention: 612.115.3:612.115.064
Svetlana Mishenina, Alexander Dygai, Pavel Madonov, Konstantin Ershov, Yulia Ravilova, Alevtina Shishkanova
28-36
About oral application of a thrombolytic based on immobilized subtilisins for thrombosis treatment: 615.015.33
Vladimir Vlasov, Alina Godzoeva, Olga Kudryashova, Olga Kozina, Olga Belyaeva, Tatiana Vavilova
37-44
Fibrin monomer in laboratory assessment of the hypercoagulable state during pregnancy: 616-005.6:618.177-089.888.11:618.3-06
Ирина Tikhomirova, Alexei, Elena Petrochenko, Yulia Malysheva, Alexander Petrochenko
45-52
Effect of nitric oxide and hydrogen sulfide donors on blood clotting parameters: 612.062:612.1+616.005
Boris Kuznik, Yuri Smolyakov, Sergei Davydov, Dmitry Parts, Nikita Andreev
53-58
Methodology for hemodynamic functions study in severe arthrosis of knee and hip joints: 617.582-583:612.135

Clinical cases

Vladimir Kolesnikov, Eugene Roitman, Aleksey Leonov
59-68
Anticoagulant treatment for severe COVID‐19 with high bleeding risk: 616-06
Giorgi Kordzakhia, Vyacheslav Yanushko, Ivan Klimchuk, Vitaliy Komissarov
69-74
Ampullar aneurysm of the popliteal vein. Recurrent pulmonary embolism. A rare clinical case of surgical treatment: 616.13-002.2
Olga Smirnova, Olesia Matvienko, Lana Tarkovskaya, Viacheslav Burakov, Vitaly Soldatenkov
75-79
Comprehensive assessment of hemostasis in a patient with an inhibitory form of hemophilia A under emicizumab treatment: 616-005.2:616.151.514-08
Stanislav Rabotinskiy, Ekaterina Bulanova, Ivan Osokin, Irina Syzova, Svetlana Dzyuba
80-84
Factor XII (Hageman) deficiency in obstetric practice: analysis of two cases: 616.151.5